NSABB calls for global guidelines for conducting, communicating research involving dangerous pathogens

NewsGuard 100/100 Score

NewScientist reports on the U.S. National Science Advisory Board for Biosecurity's (NSABB) recommendation that revised versions of two controversial studies on H5N1 avian flu be published in scientific journals, reversing its previous recommendation that the studies only be published if certain details were withheld. According to the news service, dissent among the board members over the issue has prompted the committee to "propos[e] talks to draft global guidelines for doing and communicating work involving dangerous pathogens."

"[I]nformation released this week shows that the committee was divided over the issue, strengthening the case for new guidelines," the news service writes, noting "only 12 of 18 NSABB members voted for that U-turn." "Experiments that change a pathogen's transmission or host range 'require detailed analyses of risks and benefits before they are conducted or communicated,' says the NSABB," NewScientist writes, adding, "This working group should also create some way to 'redact' papers, says the board." The news service notes, "Meanwhile, a researcher involved in the Dutch study has obtained some new results with H5N1 bird flu that give the committee's rhetoric added urgency" (MacKenzie, 4/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses